Headings Clause Example from Business Contracts

This example Headings clause appears in 20 contracts from 18 companies

Headings. The Section headings are intended for convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement.
Found in RenovoRx, Inc. contract
Cabaletta Bio, Inc. Contracts

Consulting Agreement, dated as of May 7, 2018, between the Registrant and Danforth Advisors, LLC (Filed With SEC on September 30, 2019)

SYNLOGIC, INC. Contracts

Consulting Agreement effective as of October 13, 2019, by and between the Company and Danforth Advisors, LLC, as amended (Filed With SEC on October 24, 2019)

ADURO BIOTECH, INC. Contracts

Consulting Agreement dated January 22, 2020, between the Company and Danforth Advisors, LLC (Filed With SEC on January 23, 2020)

Spero Therapeutics, Inc. Contracts

Consulting Agreement, dated November 4, 2019, by and between the Registrant and Danforth Advisors, LLC (Filed With SEC on May 8, 2020)

Generation Bio Co. Contracts

Consulting Agreement, dated September 25, 2019, by and between the registrant and Danforth Advisors, LLC (Filed With SEC on May 22, 2020)

ORGANOVO HOLDINGS, INC. Contracts

Consulting Agreement, dated September 15, 2020, by and between Organovo and Multi Dimensional Bio Insight LLC (Filed With SEC on November 5, 2020)

Consulting Agreement, dated August 25, 2020, by and between Organovo and Danforth Advisors (Filed With SEC on November 5, 2020)

Solid Biosciences Inc. Contracts

Consulting Agreement, dated as of November 19, 2020, by and between Solid Biosciences Inc. and Danforth Advisors, LLC (Filed With SEC on March 15, 2021)

Inozyme Pharma, Inc. Contracts

Amended and Restated Consulting Agreement, dated May 6, 2021, by and between the Company and Danforth Advisors, LLC (Filed With SEC on May 7, 2021)

Elicio Therapeutics, Inc. Contracts

Consulting Agreement, dated March 13, 2013, by and between the Registrant and Danforth Advisors, LLC, as amended (Filed With SEC on June 28, 2021)

Aerpio Pharmaceuticals, Inc. Contracts

Consulting Agreement, dated July 20, 2021, by and between Aadi Bioscience, Inc. and Danforth Advisors, LLC (Filed With SEC on August 27, 2021)

TENAX THERAPEUTICS, INC. Contracts

CONSULTING AGREEMENT (Filed With SEC on November 15, 2021)

Consulting Agreement dated October 14, 2021, by and between Tenax Therapeutics, Inc. and Danforth Advisors, LLC (Filed With SEC on March 29, 2022)

Arcellx, Inc. Contracts

Consulting Agreement between the Registrant and Danforth Advisors, LLC dated January 7, 2022 (Filed With SEC on January 14, 2022)

Pulmatrix, Inc. Contracts

Consulting Agreement, dated November 30, 2021, by and between Pulmatrix, Inc. and Danforth Advisors, LLC (Filed With SEC on April 15, 2022)

RenovoRx, Inc. Contracts

Consulting Agreement by and between RenovoRx, Inc. and Danforth Advisors, LLC, dated April 25, 2022 (Filed With SEC on July 19, 2022)

HISTOGENICS CORP Contracts

Consulting Agreement, effective December 21, 2018, between the Company and Danforth Advisors, LLC (Filed With SEC on December 21, 2018)

PROTEOSTASIS THERAPEUTICS, INC. Contracts

Consulting Agreement dated May 7, 2018 by and between the Company and Danforth Advisors, LLC (Filed With SEC on August 8, 2018)

AIT Therapeutics, Inc. Contracts

Consulting Agreement, effective as of October 2, 2017 by and between the Company and Danforth Advisors, LLC (Filed With SEC on May 7, 2018)

PIERIS PHARMACEUTICALS, INC. Contracts

CONSULTING AGREEMENT (Filed With SEC on March 30, 2017)